TrialAnnals of oncology : official journal of the European Society for Medical Oncology2021

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).

S Bellone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.